Journal List > Korean Circ J > v.19(2) > 1072477

Kim, Kim, Kim, Do, Park, Sohn, Ryu, Oh, Park, Choi, Seo, and Lee: Thrombolysis by Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Myocardial Infarction

Abstract

Myocardial infarction is usually associated with thrombotic occlusion of an artherosclerotic coronary artery. Reperfusion induced by administration of thrombolytic agents may presserve myocardial function and reduce mortality. At a mean of 272 minutes from symtom onset, 7 patients with acute myocardial infarction received recombinant tissue-type Plasminogen Activator.
The results are as followings:
1) Reperfusion of the infarct-related artery was observed in all of the 5 patients in whom coronary angiography was performed 19 hour after initiation of drug infusion. Ergonovine challenge test, done in 1 patient who showed normal coronary artery, did not induced coronary spasm.
2) The maximal value of Creatine Kinase and Creatine Kinase-MB(2098±2107U/L and 728±532U/L, respectively) occured at 7.2±4.3 hour, respectively. A nadir value of fibrinogen(42±21% of the preinfusion value) occured at 3.1±2.0 hour.
3) Major bleeding episodes occured in 3 patients. Major cardiac events were angina followed by percutaneous transluminal coronary angioplasty in 1 patient; cardiogenic shock in 2 patients, one of whom also experienced recurrent ventricular tachycardia;reinfarction in 1 patient, 3 of the 7 patients died.

TOOLS
Similar articles